Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health Latest News

>> UTERINE FIBROID

  • My News
  • -
  • All News

1 HOUR AGO - Yahoo! News

A Must Read - Share

FDA tightens guidelines on technique for uterine fibroid surgery

By Toni Clarke WASHINGTON (Reuters) - The U.S. Food and Drug Administration has tightened its guidelines on the use of a uterine surgical technique, saying it has been linked to the spread of a rare type of cancer. The agency said on Monday it is recommending that a boxed warning be placed on laparoscopic power morcellator devices used to treat ...

Tags: FDA tightens guidelines on technique for uterine fibroid surgery,  Uterine Fibroid Latest News

4 HOURS AGO - Huffington Post

A Must Read - Share

What Makes A City Unhappy?

I live in two of the country’s saddest cities. At least that’s if I’m to believe the results of a National Bureau of Economic Research working paper titled “Unhappy Cities.” It ranked Louisville—heart of bourbon country, home to a thriving culinary scene, and a friendly, growing place by all accounts—our nation’s third unhappiest city. Detroit—that mid-resurgence metropolis where I just ...

Tags: What Makes A City Unhappy?,  Paper Latest News

4 HOURS AGO - Huffington Post

A Must Read - Share

Why There Should Be A Pen On Your Thanksgiving Table

Turkey, cranberry relish, stuffing and a pen. Just a few necessities that should grace your Thanksgiving table. If one of these things doesn't seem quite like the others, perhaps you need to spend a little time contemplating a gratitude practice. Guests of your dinner, you see, should use the pen to write down a few things for which they feel ...

Tags: Why There Should Be A Pen On Your Thanksgiving Table,  Paper Latest News

3 HOURS AGO - Washington Times

A Must Read - Share

HealthSouth to spend $750M on home health business

BIRMINGHAM, Ala. (AP) - HealthSouth will spend about $750 million on the privately held owner of Encompass Home Health and Hospice in a deal that helps the rehabilitation hospital operator expand into home health care. The Birmingham, Alabama, company said Monday that Encompass, which is owned by EHHI ...

Tags: HealthSouth to spend $750M on home health business,  Healthsouth Latest News

3 HOURS AGO - Yahoo! News

A Must Read - Share

Amgen scraps trials of drug for advanced stomach cancer

(Reuters) - Amgen Inc on Monday said it will scrap all trials of its experimental treatment rilotumumab in patients with advanced stomach cancer, after a safety monitoring board associated it with a higher incidence of deaths. The world's largest biotechnology company said the independent safety board found that patients taking both the drug and chemotherapy had an increased number of ...

Tags: Amgen scraps trials of drug for advanced stomach cancer,  Amgen Latest News

NOV 11, 2014 - Yahoo! News

A Must Read - Share

Amgen psoriasis drug tops J&J's Stelara in Phase III study

(Reuters) - Amgen Inc said on Tuesday that its experimental psoriasis drug, brodalumab, met all the goals of a late-stage study, clearing the rough skin patches associated with the disease more thoroughly than Johnson & Johnson's Stelara and a placebo. Amgen is developing brodalumab under a multi-drug collaboration with AstraZeneca that involves splitting costs and eventual profits. After 12 weeks ...

Tags: Amgen psoriasis drug tops J&J's Stelara in Phase III study,  Amgen Latest News

4 HOURS AGO - Yahoo! News

A Must Read - Share

Merck buys rights to NewLink's experimental Ebola vaccine

(Reuters) - Merck & Co Inc will buy worldwide commercial rights to NewLink Genetics Corp's experimental Ebola vaccine. Merck will have the right to research, develop, manufacture, and distribute the vaccine, rVSV-EBOV, as well as any follow-on products, the companies said in a joint statement. Financial details were not disclosed. The Public Health Agency of Canada, which originally developed the ...

Tags: Merck buys rights to NewLink's experimental Ebola vaccine,  Merck & Co Latest News

NOV 17, 2014 - Yahoo! News

A Must Read - Share

Merck says long-term cholesterol drug study met primary endpoint

(Reuters) - Merck & Co said on Monday that its long-term Improve-It trial, which was aimed at showing whether its Zetia and Vytorin franchise does more than reduce "bad" cholesterol, had met its primary endpoint. The company will release more details on the study later this morning. (Reporting by Caroline Humer)

Tags: Merck says long-term cholesterol drug study met primary endpoint,  Merck & Co Latest News